124 related articles for article (PubMed ID: 2583753)
1. Oxidative burst capability of human monocyte subsets defined by high and low HLA-DR expression.
Spear GT; June RA; Landay AL
Immunol Invest; 1989 Oct; 18(8):993-1005. PubMed ID: 2583753
[TBL] [Abstract][Full Text] [Related]
2. Decreased oxidative burst activity of monocytes from asymptomatic HIV-infected individuals.
Spear GT; Kessler HA; Rothberg L; Phair J; Landay AL
Clin Immunol Immunopathol; 1990 Feb; 54(2):184-91. PubMed ID: 1688521
[TBL] [Abstract][Full Text] [Related]
3. Functional abolition of monocyte HLA-DR by aldehyde treatment. A novel approach to studies of class II restriction elements in antigen presentation.
Rhodes J; Tite J
J Immunol; 1988 May; 140(10):3344-51. PubMed ID: 3361123
[TBL] [Abstract][Full Text] [Related]
4. Cytofluorometric analysis of major histocompatibility antigens on human monocytes using monoclonal antibodies.
Nunez G; Stastny P
Hum Immunol; 1983 Jan; 6(1):1-11. PubMed ID: 6572620
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic differences between human blood monocyte subpopulations in psoriasis and atopic dermatitis.
Zheng M; Mrowietz U
J Dermatol; 1997 Jun; 24(6):370-8. PubMed ID: 9241965
[TBL] [Abstract][Full Text] [Related]
6. CD14++ CD16+ HLA-DR+ Monocytes in Peripheral Blood are Quantitatively Correlated with the Severity of Pre-eclampsia.
Tang MX; Zhang YH; Hu L; Kwak-Kim J; Liao AH
Am J Reprod Immunol; 2015 Aug; 74(2):116-22. PubMed ID: 25850575
[TBL] [Abstract][Full Text] [Related]
7. Human CD4+ T cells proliferate to HLA-DR+ allogeneic vascular endothelium. Identification of accessory interactions.
Savage CO; Hughes CC; McIntyre BW; Picard JK; Pober JS
Transplantation; 1993 Jul; 56(1):128-34. PubMed ID: 7687392
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of the morphological, cytochemical, immunophenotypical, and functional characteristics of normal human peripheral blood lineage(-)/CD16(+)/HLA-DR(+)/CD14(-/lo) cells, CD14(+) monocytes, and CD16(-) dendritic cells.
Almeida J; Bueno C; Algueró MC; Sanchez ML; de Santiago M; Escribano L; Díaz-Agustín B; Vaquero JM; Laso FJ; San Miguel JF; Orfao A
Clin Immunol; 2001 Sep; 100(3):325-38. PubMed ID: 11513546
[TBL] [Abstract][Full Text] [Related]
9. 1,25-Dihydroxyvitamin D3 down-regulation of HLA-DR on human peripheral blood monocytes.
Tokuda N; Mizuki N; Kasahara M; Levy RB
Immunology; 1992 Feb; 75(2):349-54. PubMed ID: 1551697
[TBL] [Abstract][Full Text] [Related]
10. Changes in monocytic expression of aminopeptidase N/CD13 after major trauma.
Huschak G; Zur Nieden K; Stuttmann R; Riemann D
Clin Exp Immunol; 2003 Dec; 134(3):491-6. PubMed ID: 14632756
[TBL] [Abstract][Full Text] [Related]
11. Cytokines in chronic inflammatory arthritis. IV. Granulocyte/macrophage colony-stimulating factor-mediated induction of class II MHC antigen on human monocytes: a possible role in rheumatoid arthritis.
Alvaro-Gracia JM; Zvaifler NJ; Firestein GS
J Exp Med; 1989 Sep; 170(3):865-75. PubMed ID: 2504878
[TBL] [Abstract][Full Text] [Related]
12. Differential MHC class II expression on human peripheral blood monocytes and dendritic cells.
Brooks CF; Moore M
Immunology; 1988 Feb; 63(2):303-11. PubMed ID: 3350576
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood and synovial fluid monocyte activation in inflammatory arthritis. I. A cytofluorographic study of monocyte differentiation antigens and class II antigens and their regulation by gamma-interferon.
Firestein GS; Zvaifler NJ
Arthritis Rheum; 1987 Aug; 30(8):857-63. PubMed ID: 3115273
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of Ia molecules by human monocytes.
Gonwa TA; Stobo JD
J Clin Invest; 1984 Sep; 74(3):859-66. PubMed ID: 6432851
[TBL] [Abstract][Full Text] [Related]
15. Internalization and acidification of surface HLA-DR molecules by epidermal Langerhans cells: a paradigm for antigen processing.
Girolomoni G; Cruz PD; Bergstresser PR
J Invest Dermatol; 1990 Jun; 94(6):753-60. PubMed ID: 2355180
[TBL] [Abstract][Full Text] [Related]
16. Incidence of HIV infection in monocyte subpopulations characterized by CD4 and HLA-DR surface density.
Schnizlein-Bick CT; Sherman MR; Boggs DL; Leemhuis TB; Fife KH
AIDS; 1992 Feb; 6(2):151-6. PubMed ID: 1558713
[TBL] [Abstract][Full Text] [Related]
17. A decrease of human leucocyte antigen-DR expression on monocytes in peripheral blood predicts stroke-associated infection in critically-ill patients with acute stroke.
Zhang DP; Yan FL; Xu HQ; Zhu YX; Yin Y; Lu HQ
Eur J Neurol; 2009 Apr; 16(4):498-505. PubMed ID: 19187263
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of monocyte class I and II histocompatibility antigen expression in man by in vivo beta-interferon.
Spear GT; Paulnock DM; Jordan RL; Meltzer DM; Merritt JA; Borden EC
Clin Exp Immunol; 1987 Jul; 69(1):107-15. PubMed ID: 3652526
[TBL] [Abstract][Full Text] [Related]
19. IL-4 decreases the expression of the monocyte differentiation marker CD14, paralleled by an increasing accessory potency.
Ruppert J; Friedrichs D; Xu H; Peters JH
Immunobiology; 1991 Aug; 182(5):449-64. PubMed ID: 1717365
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic commitment of monocytes towards a protective hemoglobin scavenging phenotype (CD14(pos)CD163(high)HLA-DR(low))following cardiopulmonary bypass.
Quimby KR; Greenidge A; Harris A; Landis RC
Cytometry B Clin Cytom; 2010 Sep; 78(5):357-60. PubMed ID: 20533393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
